Literature DB >> 23569114

The streptococcal cysteine protease SpeB is not a natural immunoglobulin-cleaving enzyme.

Helena Persson1, Reine Vindebro, Ulrich von Pawel-Rammingen.   

Abstract

The human bacterial pathogen Streptococcus pyogenes has developed a broad variety of virulence mechanisms to evade the actions of the host immune defense. One of the best-characterized factors is the streptococcal cysteine protease SpeB, an important multifunctional protease that contributes to group A streptococcal pathogenesis in vivo. Among many suggested activities, SpeB has been described to degrade various human plasma proteins, including immunoglobulins (Igs). In this study, we show that SpeB has no Ig-cleaving activity under physiological conditions and that only Igs in a reduced state, i.e., semimonomeric molecules, are cleaved and degraded by SpeB. Since reducing conditions outside eukaryotic cells have to be considered nonphysiological and IgG in a reduced state lacks biological effector functions, we conclude that SpeB does not contribute to S. pyogenes virulence through the proteolytic degradation of Igs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23569114      PMCID: PMC3676003          DOI: 10.1128/IAI.00168-13

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

Review 1.  The antioxidant properties of serum albumin.

Authors:  Marjolaine Roche; Philippe Rondeau; Nihar Ranjan Singh; Evelyne Tarnus; Emmanuel Bourdon
Journal:  FEBS Lett       Date:  2008-05-12       Impact factor: 4.124

2.  Temporal production of streptococcal erythrogenic toxin B (streptococcal cysteine proteinase) in response to nutrient depletion.

Authors:  M S Chaussee; E R Phillips; J J Ferretti
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

3.  Streptococcus pyogenes expressing M and M-like surface proteins are phagocytosed but survive inside human neutrophils.

Authors:  Leïla Staali; Matthias Mörgelin; Lars Björck; Hans Tapper
Journal:  Cell Microbiol       Date:  2003-04       Impact factor: 3.715

Review 4.  Cysteine proteinase SpeB from Streptococcus pyogenes - a potent modifier of immunologically important host and bacterial proteins.

Authors:  Daniel C Nelson; Julia Garbe; Mattias Collin
Journal:  Biol Chem       Date:  2011-12       Impact factor: 3.915

Review 5.  Albumin--an important extracellular antioxidant?

Authors:  B Halliwell
Journal:  Biochem Pharmacol       Date:  1988-02-15       Impact factor: 5.858

6.  EndoS and SpeB from Streptococcus pyogenes inhibit immunoglobulin-mediated opsonophagocytosis.

Authors:  Mattias Collin; Mikael D Svensson; Anders G Sjöholm; Jens C Jensenius; Ulf Sjöbring; Arne Olsén
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

7.  Autocatalytic processing of the streptococcal cysteine protease zymogen: processing mechanism and characterization of the autoproteolytic cleavage sites.

Authors:  J D Doran; M Nomizu; S Takebe; R Ménard; D Griffith; E Ziomek
Journal:  Eur J Biochem       Date:  1999-07

8.  Cleavage of interleukin 1 beta (IL-1 beta) precursor to produce active IL-1 beta by a conserved extracellular cysteine protease from Streptococcus pyogenes.

Authors:  V Kapur; M W Majesky; L L Li; R A Black; J M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

9.  Invasive M1T1 group A Streptococcus undergoes a phase-shift in vivo to prevent proteolytic degradation of multiple virulence factors by SpeB.

Authors:  Ramy K Aziz; Michael J Pabst; Arthur Jeng; Rita Kansal; Donald E Low; Victor Nizet; Malak Kotb
Journal:  Mol Microbiol       Date:  2004-01       Impact factor: 3.501

10.  EndoS from Streptococcus pyogenes is hydrolyzed by the cysteine proteinase SpeB and requires glutamic acid 235 and tryptophans for IgG glycan-hydrolyzing activity.

Authors:  Maria Allhorn; Arne Olsén; Mattias Collin
Journal:  BMC Microbiol       Date:  2008-01-08       Impact factor: 3.605

View more
  7 in total

Review 1.  Subterfuge and sabotage: evasion of host innate defenses by invasive gram-positive bacterial pathogens.

Authors:  Cheryl Y M Okumura; Victor Nizet
Journal:  Annu Rev Microbiol       Date:  2014-06-18       Impact factor: 15.500

2.  Prospective Evaluation of Xpert® Xpress Strep A Automated PCR Assay vs. Solana® Group A Streptococcal Nucleic Acid Amplification Testing vs. Conventional Throat Culture.

Authors:  Patricia Ferrieri; Sophie Arbefeville; Elizabeth Thonen-Kerr; K Nelson
Journal:  Curr Microbiol       Date:  2021-06-03       Impact factor: 2.188

3.  IgG protease Mac/IdeS is not essential for phagocyte resistance or mouse virulence of M1T1 group A Streptococcus.

Authors:  Cheryl Y M Okumura; Ericka L Anderson; Simon Döhrmann; Dan N Tran; Joshua Olson; Ulrich von Pawel-Rammingen; Victor Nizet
Journal:  MBio       Date:  2013-07-30       Impact factor: 7.867

4.  Secretory Proteases of the Human Skin Microbiome.

Authors:  Wisely Chua; Si En Poh; Hao Li
Journal:  Infect Immun       Date:  2021-10-04       Impact factor: 3.609

5.  Proteolytic Profiling of Streptococcal Pyrogenic Exotoxin B (SpeB) by Complementary HPLC-MS Approaches.

Authors:  Constantin Blöchl; Christoph Holzner; Michela Luciano; Renate Bauer; Jutta Horejs-Hoeck; Ulrich Eckhard; Hans Brandstetter; Christian G Huber
Journal:  Int J Mol Sci       Date:  2021-12-30       Impact factor: 5.923

6.  The Streptococcal Protease SpeB Antagonizes the Biofilms of the Human Pathogen Staphylococcus aureus USA300 through Cleavage of the Staphylococcal SdrC Protein.

Authors:  Katelyn E Carothers; Zhong Liang; Jeffrey Mayfield; Deborah L Donahue; Mijoon Lee; Bill Boggess; Victoria A Ploplis; Francis J Castellino; Shaun W Lee
Journal:  J Bacteriol       Date:  2020-05-11       Impact factor: 3.490

7.  Towards middle-up analysis of polyclonal antibodies: subclass-specific N-glycosylation profiling of murine immunoglobulin G (IgG) by means of HPLC-MS.

Authors:  Constantin Blöchl; Christof Regl; Christian G Huber; Petra Winter; Richard Weiss; Therese Wohlschlager
Journal:  Sci Rep       Date:  2020-10-22       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.